Showing results (171-180 of 201) with videos related to
Sort By:
Pageof 21
European Journal of Cancer (Oxford, England : 1990)|January 22, 2018
Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer: Individual patient data analysis of first-line randomised trials from the ARCAD databaseK L van Rooijen, Q Shi, K K H Goey, et al.Neurosci|November 1, 2024
On the Cranial NervesHugo M Libreros-Jiménez, Jorge Manzo, Fausto Rojas-Durán, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 11, 2018
Active study: undetected prevalence and clinical inertia in the treatment of breakthrough cancer pain (BTcP)C Camps Herrero, J J Reina Zoilo, D Monge Martín, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 30, 2013
Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancerA Carrato, A Gómez, P Escudero, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 5, 2017
Oncologist's knowledge and implementation of guidelines for breakthrough cancer pain in Spain: CONOCE studyR López López, C Camps Herrero, P Khosravi-Shahi, et al.Diagnostics (Basel, Switzerland)|June 26, 2025
Machine and Deep Learning for the Diagnosis, Prognosis, and Treatment of Cervical Cancer: A Scoping ReviewBlanca Vazquez, Mariano Rojas-García, Jocelyn Isabel Rodríguez-Esquivel, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 31, 2011
A phase I study of sunitinib in combination with FOLFIRI in patients with untreated metastatic colorectal cancerN Starling, F Vázquez-Mazón, D Cunningham, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 7, 2019
Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trialC Santos, D Azuara, J M Viéitez, et al.International Journal of Molecular Sciences|August 26, 2023
Anti-Diabetic Activity of Glycyrrhetinic Acid Derivatives FC-114 and FC-122: Scale-Up, In Silico, In Vitro, and In Vivo StudiesSamuel Álvarez-Almazán, Luz Cassandra Solís-Domínguez, Paulina Duperou-Luna, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 3, 2007
Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposalsF C Muñoz-Casares, S Rufián, M J Rubio, et al.Pageof 21